Orion Biotech Opportunities Corp.

Status: Pre-Deal
U=S+W/5 W=S@11.50
IPO Proceeds, $M $200.0
IPO Date May 13, 2021
CEO James Huang
Left Lead Cantor Fitzgerald
IPO Cash in Trust 100%
SPAC Tenor 24 months
IPO Sector Healthcare

Biotechnology and life sciences

IPO Geography Global
Target Company TBD
Deal Announced TBD
Deal Size, $M TBD
Deal Geography TBD
Deal Sector TBD
SEC Filings www.sec.gov

Sign up for Free Trial

No credit card required

Sign in for more data on Orion Biotech Opportunities Corp.:

  • 7 directors & officers
  • 4 filings and events
  • 1 underwriters